IPILIMUMAB
ipilimumab 50 mg/10 mL injection, 10 mL vial
IPILIMUMAB (15230N)
15230N
Manner of administration:Injection
Restriction (Streamlined authority code: 18071)
Indication: Immunotherapy sensitive advanced or metastatic cancer
Quantities & Cost
